Bioceres Crop Solutions Corp

Bioceres Crop Solutions reported fourth-quarter revenue of $55.9 million, slightly above the $55.4 million posted a year earlier, while full-year fiscal 2026 revenue declined 18% to $238 million. Fourth-quarter Crop Nutrition revenue rose 36% year-over-year on strong microbeaded fertilizer performance, offsetting lower crop protection and seed sales, but reported gross profit slipped 6% to $12.7 million at a 22.8% margin after roughly $4 million in non-recurring inventory obsolescence charges. Adjusted EBITDA for the quarter turned positive at $0.6 million, an improvement of about $10 million from negative $9.6 million a year earlier, as SG&A fell 19%, while full-year adjusted EBITDA declined 12% to $25.5 million from $28.9 million. Total financial debt stood at $225.9 million as of June 30 against $12.2 million in cash and short-term investments, leaving net financial debt of $213.6 million, with $118.6 million of secured notes classified as short-term amid an ongoing acceleration dispute with noteholders. The company reprofiled approximately $28 million of bank debt obligations at Rizobacter and completed a voluntary maturity extension for $46.5 million in aggregate principal of local bonds in Argentina, and it is targeting roughly 40% gross margins from fiscal 2027 onward and combined SG&A of 23% of revenues by fiscal 2028.